Thread
:
PPI use linked to worse outcomes in urothelial cancer patients treated with atezolizu
View Single Post
09-17-2020, 05:34 PM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 18,951
PPI use linked to worse outcomes in urothelial cancer patients treated with atezolizu
Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with the immunotherapeutic atezolizumab (Tecentriq), compared with patients who did not use PPIs.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News